Patients Quietly Rewrite Their Own Prescriptions, and Their Bodies Are the Guide

Millions of people living with chronic disease do something their doctors rarely hear about: they quietly rewrite their own prescriptions. They skip doses, halve tablets, shift pill times to fit their routines, swap medications for foods they believe work just as well, or stop treatment altogether for days at a time. A new qualitative study from the University of Geneva, published in the Journal of General Internal Medicine, has now documented in unusual detail how and why patients with long-term conditions take medication decisions into their own hands, often without ever telling the physician who wrote the prescription. The findings paint a picture that is neither simple defiance nor careless forgetting, but a deliberate, emotionally charged, and surprisingly systematic form of self-experimentation.

The research team, led by pharmacist and PhD researcher Beatriz Santos, interviewed 30 ambulatory patients in Geneva, Switzerland, between July and December 2022, ultimately analyzing the accounts of 24 adults living with chronic conditions such as diabetes, hypertension, and respiratory disease. To be included, participants had to have been on a prescribed medication for at least six months and to have modified their intake at least once in the previous year without consulting a healthcare professional first. The interviews, conducted in French and lasting an average of 35 minutes, were transcribed, verified, and analyzed using a low-inference qualitative descriptive approach with MAXQDA software, a method chosen to stay as close as possible to participants’ own words rather than imposing heavy theoretical interpretation. Recruitment deliberately avoided stigmatizing language such as “non-adherent,” a choice the researchers say was essential for getting people to open up about behavior they often keep hidden.

What emerged was a wide repertoire of adjustment techniques. Participants reported skipping or reducing doses, temporarily interrupting treatment, splitting a single daily dose across the day, altering the timing of intake, and replacing pharmaceutical products with non-pharmacological alternatives. The medications involved ranged from preventive therapies such as antihypertensives, metformin, calcium, and vitamin supplements to insulin and other diabetes treatments. Notably, the researchers encouraged participants to discuss all of their medications, not just those for the conditions they were recruited through, reflecting the multimorbid reality of most chronic patients, who in this study carried an average of 2.3 chronic conditions each.

Perhaps the most striking finding is what the researchers call using the body as a compass. Many participants described relying on physical sensations, symptoms, or intuition as their primary guide for deciding when and how much medication to take, sometimes explicitly prioritizing these bodily signals over medical advice. One participant explained how leg pain served as a rough glucose meter, allowing him to estimate his blood sugar from where the pain stopped in his leg. Another insisted on the right to test things personally, saying that even if the diabetologist had insisted on a dose, he wanted first to see what was happening inside his own body, because, as he put it, it is his body and it belongs to him. The researchers interpret this as a form of experiential knowledge: rather than passively following prescriptions, these patients engage in dynamic self-monitoring, tailoring treatment to perceived needs through observation, trial, and error.

Interestingly, this bodily compass can be partly displaced by technology. Several participants described how monitoring devices, such as continuous glucose sensors or home blood pressure monitors, shifted their adjustment decisions from subjective feelings toward objective numbers. One participant reported interrupting insulin for the exact number of days her glucose sensor was removed, since without the device she could not measure her blood sugar at all. Another began checking her blood pressure at home and skipping her telmisartan whenever the reading was low, replacing a vague sense of fatigue-driven guessing with a numeric threshold. The authors note a double edge here: as patients delegate self-monitoring to devices, they may become less attuned to their own symptoms, creating a potential vulnerability whenever access to the technology is interrupted.

Why do patients do this? The dominant driver, the study found, is a perceived lack of need or benefit. Consistent with the Health Belief Model, a well-established psychological framework linking health behavior to perceived susceptibility, severity, benefits, and barriers, participants who felt no symptoms, particularly those on preventive treatments for osteoporosis or hypertension, struggled to see the point of daily pills. Some substituted what they considered natural equivalents: eating more Parmesan cheese for iron, drinking orange juice for vitamin D, or relying on dairy products instead of calcium supplements, occasionally with visible confusion between vitamins. Others adjusted to cope with medication overload, with one participant joking that the pile of pills she took daily could almost be spread on toast. Practical barriers mattered too: injections that hurt, pills too large to swallow discreetly in restaurants, side effects that ruined holidays, demanding work weeks in which a hypoglycemic episode felt unmanageable, and even insurance reimbursement limits that pushed one patient to plan dose reductions toward the end of the year.

Beneath these practical calculations lies a hidden hierarchy. Participants consistently ranked their medications, treating some as untouchable and others as negotiable. Long-standing treatments, woven into habit and routine, were considered more important and less likely to be adjusted, while newer additions, supplements, and preventive therapies sat lower on the ladder. The clinical context of prescription also weighed heavily: medications initiated after frightening events, such as a minor stroke, were regarded as essential, with one participant singling out her aspirin as non-negotiable for precisely that reason. The researchers argue that recognizing this patient-constructed frame of reference, which may diverge sharply from clinical priorities, is essential for any realistic conversation about adherence.

The emotional texture of self-adjustment is ambivalent. Participants described feelings of freedom, control, and empowerment, a sense of being the true experts on their own conditions, with one declaring that the patient is their best doctor. Yet the same decisions frequently produced guilt, anxiety, and an internal conflict that made medication management painful. One participant described the liberation of deciding not to take a pill, immediately followed by the recognition that she was not really free, because she knew she was doing something not right for her health. Fear of judgment kept many from disclosing these behaviors to prescribers, with some preferring to let six-monthly blood tests reveal the truth rather than face a lecture. Where physicians responded rigidly, patients described feeling like scolded schoolchildren and reluctantly resuming treatment; where physicians validated their reasoning, patients reported strengthened autonomy and a more honest relationship.

The study’s authors, whose protocol was approved by the Geneva Regional Research Ethics Committee and whose recruitment spanned pharmacies, hospital outpatient clinics, primary care centers, and patient associations, are careful about the limits of their work. Participants were highly educated, all came from a single French-speaking canton, and those willing to discuss such sensitive behavior may differ from those who are not. Still, the team reached thematic saturation, with later interviews generating no new insights, and they argue the descriptive foundation now justifies quantitative research into how common specific adjustment behaviors are and how they affect clinical outcomes. Their prescription for change is clear: patients need safer, more informed pathways to do what many are already doing anyway. That means patient education programs on medication adjustment, collaborative care frameworks, and above all a shift from directive, one-size-fits-all prescribing toward genuine dialogue in which patients feel heard, respected, and able to experiment openly with their clinicians rather than in secret. As the authors conclude, acknowledging both the clinician’s expertise and the patient’s agency may be the only way to close the gap between what is prescribed and what is actually taken.

Subject of Research: Patient self-adjustment of long-term medication regimens without consulting healthcare providers

Article Title: Self-Adjusting Long-Term Medications: A Qualitative Descriptive Study of Patients’ Practices

Article References: Self-Adjusting Long-Term Medications: A Qualitative Descriptive Study of Patients’ Practices. (n.d.). https://doi.org/10.1007/s11606-026-10842-4

Image Credits: AI Generated

DOI: 10.1007/s11606-026-10842-4

Keywords: medication adherence, self-adjustment, chronic disease, qualitative research, patient-provider communication, diabetes, hypertension, Health Belief Model, self-management, patient education, shared decision-making, prescription drugs